Nuvisan

NUVISAN is a leading CRO/CDMO with extensive pharma expertise and end-to-end scientific capabilities spanning drug discovery, clinical trials, bioanalytics and pharmaceutical manufacturing. Headquartered in Neu-Ulm and with six sites across Germany and France, NUVISAN originated from a spin-out of Bayer R&D functions in 2020 and serves pharmaceutical and biotech customers worldwide.